Clinical trials and multi-center collaborative prospective cohorts have led to new insights into predictors of treatment response and refinement of IESS treatment. Novel research tools and technological advances have uncovered potential neurobiological mechanisms underlying IESS.
Boston Children’s Hospital through the Infantile Epileptic Spams Program and other research groups have been at the forefront of the outstanding clinical care and research productivity related to IESS. On October 11th these groups will come together for a symposium to explore the prospects of coordinating our collective efforts more closely to improve outcomes of babies with infantile epileptic spasms.
The goals are to:
Disseminate recent clinical and translational IESS-related research results from BCH faculty and from our colleagues locally to pediatric neurologists and basic science researchers at BCH and surrounding institutions.
Foster a connected and cohesive IESS-related research network.
Develop new collaborative clinical and translational IS-related research projects with BCH and the surrounding institutions.
The event will be sponsored by the Intellectual and Developmental Disabilities Center and the Rosamund Stone Zander Translational Neuroscience Center and led by Dept of Neurology’s Dr. Chris Yuskaitis (IDDRC member) and Dr. Chellamani Harini co-leaders of the Infantile Spasms Program at BCH.
Discussion
By posting you agree to the Terms and Privacy Policy.